Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Staging
9 results:

  • 1. [Multicenter real-world study on safety and efficacy of neoadjuvant therapy in combination with immunotherapy for colorectal cancer].
    Liu XZ; Xiong Z; Xiao BY; Yu GY; Li YJ; Yao YF; Tao KX; Ding PR; Zhang W; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):219-227. PubMed ID: 35340171
    [No Abstract]    [Full Text] [Related]  

  • 2. A high density of PD-L1-expressing immune cells is significantly correlated with favorable disease free survival in nonmetastatic colorectal cancer.
    Kuo YT; Liao CK; Chen TC; Lai CC; Chiang SF; Chiang JM
    Medicine (Baltimore); 2022 Jan; 101(3):e28573. PubMed ID: 35060518
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer].
    Han ZH; Chen JJ; Feng N; Niu PF; Song C; Gao ZY; Gao QK; Ji DB; Wang WB; Lei FM; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):966-971. PubMed ID: 31630495
    [No Abstract]    [Full Text] [Related]  

  • 4. The impact of microsatellite stability status in colorectal cancer.
    Gupta R; Sinha S; Paul RN
    Curr Probl Cancer; 2018 Nov; 42(6):548-559. PubMed ID: 30119911
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Association of programmed cell death 1 (pdcd1) gene polymorphisms with colorectal cancer among Han Chinese population].
    Zhao Y; Mao Z; Pang H; Zhao X; Zhang S; Gao Z; Yang Y; Fang T; Ma Q; Ma X; Wang Y; Zhang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Apr; 35(2):219-223. PubMed ID: 29652996
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Implications of the tumor immune microenvironment for staging and therapeutics.
    Taube JM; Galon J; Sholl LM; Rodig SJ; Cottrell TR; Giraldo NA; Baras AS; Patel SS; Anders RA; Rimm DL; Cimino-Mathews A
    Mod Pathol; 2018 Feb; 31(2):214-234. PubMed ID: 29192647
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunoprofiling as a predictor of patient's response to cancer therapy-promises and challenges.
    Bethmann D; Feng Z; Fox BA
    Curr Opin Immunol; 2017 Apr; 45():60-72. PubMed ID: 28222333
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.
    Schaefer T; Satzger I; Gutzmer R
    Medicine (Baltimore); 2017 Jan; 96(1):e5753. PubMed ID: 28072717
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrative Analyses of colorectal cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.
    Mlecnik B; Bindea G; Angell HK; Maby P; Angelova M; Tougeron D; Church SE; Lafontaine L; Fischer M; Fredriksen T; Sasso M; Bilocq AM; Kirilovsky A; Obenauf AC; Hamieh M; Berger A; Bruneval P; Tuech JJ; Sabourin JC; Le Pessot F; Mauillon J; Rafii A; Laurent-Puig P; Speicher MR; Trajanoski Z; Michel P; Sesboüe R; Frebourg T; Pagès F; Valge-Archer V; Latouche JB; Galon J
    Immunity; 2016 Mar; 44(3):698-711. PubMed ID: 26982367
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.